IGENE Biotechnology, Inc. (Public, OTC:IGNE) is engaged in supplying, producing and marketing specialty biochemical products.
Igene's natural Astaxanthin is used primarily as a source of pigment in fish feed for salmonids. Igene sells the commercial product under the trademark Aquasta®
Igene is also focused on research and development in the areas of fermentation technology, nutrition and health, and the marketing of products and applications globally. The wholly owned subsidiary of the Company is Igene Chile Commercial, Ltda. On January 8, 2009, Igene entered into an agreement with Archer-Daniels-Midland Company (ADM), pursuant to which the Company and ADM formed a joint venture (the ADM JV) to manufacture and sell astaxanthin and derivative products globally.
2003-2007: Joint Venture with Tate & Lyle produces Aquasta™ in Selby, UK
2009-2011: Joint Venture with Archer Daniels Midland produces Aquasta® in the United States
2013: Contract manufacturing of Aquasta® in Europe